Oxford BioDynamics (Oxford BioDynamics) Gross-Profit-to-Asset % : 1.62% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Oxford BioDynamics's annualized Gross Profit for the quarter that ended in Sep. 2023 was $0.30 Mil. Oxford BioDynamics's average Total Assets over the quarter that ended in Sep. 2023 was $18.65 Mil. Therefore, Oxford BioDynamics's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 1.62%.

Oxford BioDynamics Gross-Profit-to-Asset % Historical Data

The historical data trend for Oxford BioDynamics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Gross-Profit-to-Asset % Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

2.17

-1.02

2.31

0.77

2.01

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial														9.99	1.11	0.44	2.32	1.62

Competitive Comparison of Oxford BioDynamics's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Oxford BioDynamics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Gross-Profit-to-Asset % falls into.

Oxford BioDynamics Gross-Profit-to-Asset % Calculation

Oxford BioDynamics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Sep. 2023 )	/	( (Total Assets (A: Sep. 2022 )	+	Total Assets (A: Sep. 2023 ))	/ count )
	=	0.329	/	( (12.847	+	19.959)	/ 2 )
	=	0.329	/	16.403
	=	2.01 %

Oxford BioDynamics's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	0.302	/	( (17.333	+	19.959)	/ 2 )
	=	0.302	/	18.646
	=	1.62 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Oxford BioDynamics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.